The decreases in SIRT1 can be attributed to a decrease in the NAD+ levels caused by PARP activation, which inhibits the AMPK/PGC1α signaling pathway, inducing DKD pathogenesis [220]. Here, PPARGC1A is linked to diabetic kidney disease.